Thapsigargin Is a Broad-Spectrum Inhibitor of Major Human Respiratory Viruses: Coronavirus, Respiratory Syncytial Virus and Influenza A Virus

The long-term control strategy of SARS-CoV-2 and other major respiratory viruses needs to include antivirals to treat acute infections, in addition to the judicious use of effective vaccines. Whilst COVID-19 vaccines are being rolled out for mass vaccination, the modest number of antivirals in use o...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Beltagi, Sarah, Preda, Cristian Alexandru, Goulding, Leah V., James, Joe, Pu, Juan, Skinner, Paul, Jiang, Zhimin, Wang, Belinda Lei, Yang, Jiayun, Banyard, Ashley C., Mellits, Kenneth H., Gershkovich, Pavel, Hayes, Christopher J., Nguyen-Van-Tam, Jonathan, Brown, Ian H., Liu, Jinhua, Chang, Kin-Chow
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913267/
https://www.ncbi.nlm.nih.gov/pubmed/33546185
http://dx.doi.org/10.3390/v13020234

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913267/
https://www.ncbi.nlm.nih.gov/pubmed/33546185
http://dx.doi.org/10.3390/v13020234

Ejemplares similares